GenFlat Holdings, Inc.

GenFlat Holdings, Inc.

Overview

GenFlat Holdings, Inc. (formerly Healthcare Business Resources Inc.; ticker: GFLT) is an early-stage container sales and leasing company focused on GenFlat Containers, a patented collapsible intermodal-marine container system. Four collapsed GenFlat Containers stack to the volume of one conventional high-cube container. The company offers short- and long-term leases and plans eventual sales to replace traditional marine containers in customer fleets.

Products and technology

• GenFlat Container variants:
  • 20-foot standard collapsible container
  • 40-foot standard container
  • 40-foot high-cube collapsible container
• Key benefits:
  • Space efficiency: four collapsed units occupy the space of one conventional high-cube container
  • Potential cost savings: reduced freight, terminal handling, transloading fees; lower fuel use and emissions; reduced storage and yard space requirements
• Collapse/expand mechanism:
  • GenFlat Genny (patent pending) or GenFlat Actuator
  • Collapse/expand in about 80 seconds
• Standards: GenFlat Containers meet ISO and Lloyd’s Registry standards

Intellectual property

• U.S.: five patents on GenFlat Containers, one patent on the Actuator
• China: two patents on GenFlat Containers, one patent on the Actuator
• Genny: patent pending in the U.S. and China; applications filed in South Africa, UAE, and Saudi Arabia
• Protection relies on patents, trade secrets, and confidentiality agreements; potential litigation risk exists for infringements

Manufacturing and suppliers

• Manufacturer: China International Mariner Containers (CIMC), Dalian, China
• Relationship: exclusive Teaming Agreement with CIMC to manufacture GenFlat Containers
• Company exposure: dependency on CIMC creates risk if the manufacturer faces disruptions or pricing pressures, with limited alternative suppliers and potential cross-border dispute challenges

Markets, customers, and sales pipeline

• Commercial activities began in May 2024
• Current agreements: one rental agreement, two equipment lease agreements, and four trial agreements
• Total customers: seven
• Named customers under trial/leases:
  • Arkas Line
  • Maersk Logistics & Services Canada, Inc.
  • Group Global One
  • Global Railway Engineering
• Upcoming leases: MarPro Lease and BAFCO Lease expected to begin December 2026
• Qualified sales pipeline (as of June 30, 2026): approximately $400 million in potential contract value
• Management conversion estimate: about 28% of the pipeline could convert to signed agreements during calendar year 2027

Financials and economics

• Revenue status: nominal revenue to date
• Profitability: not yet profitable; ongoing losses
• Net loss (fiscal year ended June 30):
  • 2026: $3,315,190
  • 2025: $4,713,546
• Cumulative deficit (as of June 30, 2026): $11,093,510
• Going concern: auditors issued a going-concern opinion for the June 30, 2026 financial statements; management depends on additional financing and future revenue to achieve profitability
• Financing outlook: plan to raise capital through equity offerings; additional financing may be needed to fund operations and expansion

Employees and location

• U.S. employees: four full-time and one part-time
• Headquarters: 1983 N Berra Blvd, Tooele, UT 84074, USA
• Main operations conducted from approximately 1,500 square feet of office space

Corporate history and status

• Formed in 2019 as Healthcare Business Resources Inc.
• 2023-12-20: completed share exchange where GenFlat, Inc. became the controlling entity; health-care consulting activities discontinued
• 2024-05-09 (effective 2024-05-17): amended charter to change name to GenFlat Holdings, Inc. and authorize a 1-for-100 reverse split
• Post-split outstanding shares: 10,541,500; CUSIP: 42240P205
• Since June 2024: operates globally through 97.22%-owned GenFlat, Inc.
• 2026: classified as an emerging growth company and a smaller reporting company under SEC rules

Risks and regulatory/operational context

• Public market: trading market limited to OTCQB; penny-stock considerations apply
• Manufacture and supply: substantial dependence on CIMC and China-based manufacturing
• Financial position: early-stage company with ongoing net losses, negative cash flow, and a going-concern qualification
• Capital needs: additional financing likely required to sustain operations and support expansion
• International exposure: cross-border regulatory, currency, and geopolitical risks
• Reporting and compliance: internal control weaknesses identified and ongoing compliance costs associated with public reporting

Key dates and figures

• Primary corporate name change and reverse split effective: May 17, 2024
• Outstanding post-reverse-split shares: 10,541,500
• As of September 25, 2026: approximately 13,105,234 shares outstanding
• Qualified pipeline: ~$400 million (as of June 30, 2026) with an estimated 28% potential conversion in 2027